Shopping cart ITEMS
 modern scholarly publishers in the finest tradition
Login Register
Home
Books
Journals
References
A-Z Index
Author Index
For Our Authors
User Area
Shopping Cart
Contact
Electronic Data Center

Journal of Environmental Pathology, Toxicology and Oncology

 

ISSN for PRINT: 0731-8898

Institutional price:

$672.00

Issues per year:

4

For Online Access

Best Paper Award Selection - Editorial Board Site

Add subscription to shopping cart

2004, Volume23

Issue 2

  90 pages  

DOI: 10.1615/JEnvPathToxOncol.v23.i2   

click 'Save as...' here to save XML metadata

Issue price - $160.00  

Add to shopping cart

  • Relevance of Radioprotectors in Radiotherapy: Studies with Tocopherol Monoglucoside
  • Cherupally Krishnan K. Nair
    Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Bombay, India

    Veena Salvi
    Radiation Biology and Health Sciences Division, Bhabha Atomic Research Center, Mumbai, India

    Tsutomu V. Kagiya
    Health Research Foundation, Kinki Invention Center, Kyoto, Japan

    Rema Rajagopalan
    Radiation Biology Division, Bhabha Atomic Research Centre, Bombay, India


    ABSTRACT

    Radioprotective compounds are of importance in clinical radiation therapy, because normal tissues should be protected against radiation injury while using higher doses of radiation to obtain better cancer control. We investigated the radioprotection of cellular DNA in cancer and in various cells and tissues, in a murine system following exposure to γ-radiation and tocopherol monoglucoside (TMG) administration. We used single-cell gel electrophoresis (comet assay) and studied the progression of murine fibrosarcoma following radiation exposure and administration of TMG. The administration of TMG to tumor-bearing mice protected the cellular DNA against radiation-induced strand breaks as shown by the decrease in comet tail length, tail moment, and percentage of DNA in the tails of the cells of normal tissues. The same parameters were not altered in the cells of fibrosarcoma. Our results showed that the administration of TMG immediately after exposure to γ-radiation can protect normal tissues against radiation damages in tumor-bearing mice. Local γ-radiation exposure (5 Gy) of the tumor retarded the tumor growth. Administration of TMG did not protect cancer cells from radiation damage because the growth curves of cancer cells treated with radiation alone and those treated with TMG after irradiation were not significantly different.

    DOI: 10.1615/JEnvPathToxOncol.v23.i2.80

    Download article, 8 pages

    Article price - $35.00  

    Add to shopping cart

    << Previous article  

    Designed by offsiteteam Designed by offsiteteam Designed by offsiteteam
    Begell House Inc.
    50 Cross Highway,
    Redding, CT 06896
    TEL (203) 938 1300
    FAX (203) 938 1304
    orders@begellhouse.com